Treatment of pyoderma gangrenosum: A multicenter survey-based study assessing satisfaction and quality of life

Misty M. Hobbs, Rebecca Byler, Emile Latour, Lauren Bonomo, Kerry Hennessy, Carla N. Cruz-Diaz, Michi M. Shinohara, Lucia Seminario-Vidal, Kanade Shinkai, Alex G. Ortega-Loayza

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Pyoderma gangrenosum (PG) lacks consensus regarding treatment, and no prior studies assess treatment satisfaction in PG. The objective of this study was to determine patient-reported satisfaction in the treatment of PG, and associations with satisfaction. Methodology was a multicenter cross-sectional survey for patients who received systemic medication(s) to treat PG. Thirty-five patients completed the survey (mean age: 54.0 years, 65.7% female, response rate: 81.4%). Mean (± SD) SATMED-Q score was 75.0 (±16.2, range: 67.6-85.3). Older patients (72.6 ± 23.6 for 18-39 years, 74.4 ± 16.1 for 40-59, 77.1 ± 11.6 for 60+), plus those with higher incomes (72.9 ± 20.3 for $0-49 000; 74.0 ± 17.6 for $50 000-99 000; 79.0 ± 14.6 for $100 000+) and education status (69.4 ± 14.3 for high school equivalent, 72.9 ± 15.9 for undergraduate, 91.7 ± 10.6 for graduate), were more satisfied with treatment. Ulcerative PG had higher SATMED-Q scores (79.0 ± 13.2) than other subtypes (66.2 ± 19.3). For local therapy, wound care, or pain control, 63.2%, 100%, and 75% were satisfied, respectively. The mean DLQI was 8.6 (±7.6, range: 0-29), and higher DLQI was associated with decreased satisfaction. Satisfaction with providers was positively correlated with global satisfaction (Pearson's r = 0.638). The presence of pain and/or depression influenced both SATMED-Q (72.8 ± 18.8 with pain, 78.3 ± 11.2 without; 68.2 ± 18.8 with depression, 80.1 ± 12.2 without) and DLQI scores (12.1 ± 8.1 with pain, 3.9 ± 3.4 without; 10.3 ± 7.1 with depression, 7.4 ± 8.0 without). To optimize the patient experience, non-modifiable associations should be individually considered, and potentially modifiable associations such as satisfaction with specific providers, pain, and depression, may be targeted for management.

Original languageEnglish (US)
Article numbere14736
JournalDermatologic Therapy
Volume34
Issue number2
DOIs
StatePublished - Mar 1 2021

Keywords

  • pyoderma gangrenosum
  • quality of life
  • satisfaction
  • survey
  • treatment

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'Treatment of pyoderma gangrenosum: A multicenter survey-based study assessing satisfaction and quality of life'. Together they form a unique fingerprint.

Cite this